Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dhingra

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Investigational New Drugs|September 1, 1988
Phase II study of tiazofurin (NSC 286193) in the treatment of advanced small cell bronchogenic carcinomaP Y Holoye, D T Carr, H M Dhingra, et al.
Plos One|January 7, 2017
Technical Insights into Highly Sensitive Isolation and Molecular Characterization of Fixed and Live Circulating Tumor Cells for Early Detection of Tumor InvasionSophie Laget, Lucile Broncy, Katia Hormigos, et al.
Investigational New Drugs|September 30, 2005
Phase I trial of oral talactoferrin alfa in refractory solid tumorsTeresa G Hayes, Gerald F Falchook, Gauri R Varadhachary, et al.
Cancer|October 15, 1983
High-dose chemotherapy and autologous bone marrow transplantation for the treatment of small cell lung carcinomaP Farha, G Spitzer, M Valdivieso, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1988
Combined chemoradiotherapy in limited-disease, inoperable non-small cell lung cancerT Umsawasdi, M Valdivieso, H T Barkley, et al.
International Journal of Radiation Oncology, Biology, Physics|May 1, 1987
Timing of elective brain irradiation: a critical factor for brain metastasis-free survival in small cell lung cancerJ S Lee, T Umsawasdi, H T Barkley, et al.
Cancer|June 15, 1987
Use of carcinoembryonic antigen in small cell lung cancer. Prognostic value and relation to the clinical course 1F Laberge, H A Fritsche, T Umsawasdi, et al.
Cancer|November 15, 1989
Weekly doxorubicin versus doxorubicin every 3 weeks in cyclophosphamide, doxorubicin, and cisplatin chemotherapy for non-small cell lung cancerT Umsawasdi, M Valdivieso, D J Booser, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 1985
Esophageal complications from combined chemoradiotherapy (cyclophosphamide + Adriamycin + cisplatin + XRT) in the treatment of non-small cell lung cancerT Umsawasdi, M Valdivieso, H T Barkley, et al.
Cancer Treatment Reports|April 1, 1984
Chemotherapy for advanced adenocarcinoma and squamous cell carcinoma of the lung with etoposide and cisplatinH M Dhingra, M Valdivieso, D J Booser, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Investigational New Drugs|September 1, 1988
Phase II study of tiazofurin (NSC 286193) in the treatment of advanced small cell bronchogenic carcinomaP Y Holoye, D T Carr, H M Dhingra, et al.
Plos One|January 7, 2017
Technical Insights into Highly Sensitive Isolation and Molecular Characterization of Fixed and Live Circulating Tumor Cells for Early Detection of Tumor InvasionSophie Laget, Lucile Broncy, Katia Hormigos, et al.
Investigational New Drugs|September 30, 2005
Phase I trial of oral talactoferrin alfa in refractory solid tumorsTeresa G Hayes, Gerald F Falchook, Gauri R Varadhachary, et al.
Cancer|October 15, 1983
High-dose chemotherapy and autologous bone marrow transplantation for the treatment of small cell lung carcinomaP Farha, G Spitzer, M Valdivieso, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1988
Combined chemoradiotherapy in limited-disease, inoperable non-small cell lung cancerT Umsawasdi, M Valdivieso, H T Barkley, et al.
International Journal of Radiation Oncology, Biology, Physics|May 1, 1987
Timing of elective brain irradiation: a critical factor for brain metastasis-free survival in small cell lung cancerJ S Lee, T Umsawasdi, H T Barkley, et al.
Cancer|June 15, 1987
Use of carcinoembryonic antigen in small cell lung cancer. Prognostic value and relation to the clinical course 1F Laberge, H A Fritsche, T Umsawasdi, et al.
Cancer|November 15, 1989
Weekly doxorubicin versus doxorubicin every 3 weeks in cyclophosphamide, doxorubicin, and cisplatin chemotherapy for non-small cell lung cancerT Umsawasdi, M Valdivieso, D J Booser, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 1985
Esophageal complications from combined chemoradiotherapy (cyclophosphamide + Adriamycin + cisplatin + XRT) in the treatment of non-small cell lung cancerT Umsawasdi, M Valdivieso, H T Barkley, et al.
Cancer Treatment Reports|April 1, 1984
Chemotherapy for advanced adenocarcinoma and squamous cell carcinoma of the lung with etoposide and cisplatinH M Dhingra, M Valdivieso, D J Booser, et al.
Pageof 7